Aladdin Healthcare Technologies Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Wade Menpes-Smith
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | no data |
| Participación del CEO | 14.8% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 4yrs |
Actualizaciones recientes de la dirección
Recent updates
CEO
Wade Menpes-Smith
no data
Permanencia
Mr. Wade Menpes-Smith serves as Chief Executive Officer, Managing Director & Chairman of the Board of Directors at Aladdin Healthcare Technologies SE (formerly known as Aladdin Blockchain Technologies Hold...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman of the Board | no data | sin datos | 14.8% € 39.9k | |
| Deputy Chairman & COO | no data | sin datos | sin datos | |
| CFO & Director | 2.2yrs | sin datos | sin datos | |
| Member of Drug Discovery Advisory Board & Chief Scientific Advisor | 2.3yrs | sin datos | sin datos | |
| Member of Early Diagnosis Advisory Board & Adviser of Early Stage Drug Discovery | 4yrs | sin datos | sin datos | |
| Member of Drug Advisory Board & Adviser of Neurological Research | 4yrs | sin datos | sin datos | |
| Member of Early Diagnosis Advisory Board & Adviser of Aging | 4yrs | sin datos | sin datos | |
| Member of Early Diagnosis Advisory Board & Adviser of Biological Research | 4yrs | sin datos | sin datos | |
| Member of Drug Advisory Board & Adviser of Cardiovascular | 4yrs | sin datos | sin datos | |
| Member of Drug Discovery Advisory Board & Adviser of Medical Imaging | 4yrs | sin datos | sin datos | |
| Member of Drug Discovery Advisory Board & Adviser of Biobank | 3.1yrs | sin datos | sin datos |
4.0yrs
Permanencia media
Junta con experiencia: La junta directiva de NMI se considera experimentada (4 años de antigüedad promedio).